The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 29, 2013
Filed:
May. 06, 2011
Xinghai Chen, San Antonio, TX (US);
Qiuli Huang, San Antonio, TX (US);
Harry Kochat, San Antonio, CA (US);
Andrey Malakhov, San Antonio, TX (US);
Frederick H. Hausheer, Fair Oaks Ranch, TX (US);
Xinghai Chen, San Antonio, TX (US);
Qiuli Huang, San Antonio, TX (US);
Harry Kochat, San Antonio, CA (US);
Andrey Malakhov, San Antonio, TX (US);
Frederick H. Hausheer, Fair Oaks Ranch, TX (US);
BioNumerik Pharmaceuticals, Inc., San Antonio, TX (US);
Abstract
The present invention discloses: (i) two novel deuterated Karenitecin® analogs, pharmaceutically-acceptable salts, and/or derivatives thereof; (ii) methods of synthesis of said novel deuterated Karenitecin® analogs, pharmaceutically-acceptable salts, and/or derivatives thereof; (iii) pharmaceutically-acceptable formulations comprising said novel deuterated Karenitecin® analogs, pharmaceutically-acceptable salts, derivatives thereof; and/or, optionally, one or more additional chemotherapeutic agents; and (iv) methods of administration of said novel deuterated Karenitecin® analogs, pharmaceutically-acceptable salts, derivatives thereof; and/or, optionally, one or more additional chemotherapeutic agents, to subjects in need thereof.